Baillie Gifford - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 217 filers reported holding SORRENTO THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.

Quarter-by-quarter ownership
Baillie Gifford ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$1,336
-59.4%
3,7110.0%0.00%
Q4 2022$3,288
-45.2%
3,7110.0%0.00%
Q3 2022$6,000
-33.3%
3,711
-14.0%
0.00%
Q2 2022$9,000
-10.0%
4,3140.0%0.00%
Q1 2022$10,000
-50.0%
4,3140.0%0.00%
Q4 2021$20,000
-39.4%
4,3140.0%0.00%
Q3 2021$33,000
-34.0%
4,314
-16.3%
0.00%
Q2 2021$50,000
+8.7%
5,152
-6.9%
0.00%
Q1 2021$46,000
+31.4%
5,531
+8.3%
0.00%
Q4 2020$35,0005,1090.00%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
HUNTINGTON NATIONAL BANK 15,001$1,4100.00%
KLCM Advisors, Inc. 20,000$1,8800.00%
AlphaMark Advisors, LLC 3,135$00.00%
TRUST CO OF VERMONT 204$190.00%
SlateStone Wealth, LLC 30,866$30.00%
Coppell Advisory Solutions LLC 100$890.00%
Highlander Capital Management, LLC 1,200$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Russell Investments Group, Ltd. 266$250.00%
OGOREK ANTHONY JOSEPH /NY/ /ADV 3,600$00.00%
View complete list of SORRENTO THERAPEUTICS INC shareholders